Skip to main content
. 2021 Mar 31;22(7):3613. doi: 10.3390/ijms22073613

Table 1.

PWS mouse models and involved genes.

Gene(s) of Interest. Name, Aliases Phenotype References
all (UPD Chr 7) T(7;18)50H/+
(JAX001816, https://www.jax.org/strain/001816, accessed on 20 March 2021)
postnatal lethality (100%)
growth retardation
[55] *
all (6.8 Mb deletion) PWS∆LMP2A
TgPWS/AS(del)
Del(7Herc2-Mkrn3)13FRdni/+
fetal growth retardation
postnatal growth retardation
neonatal lethality (100%)
reduced movement
irregular respiratory rate
hypoglycemia
pancreatic apoptosis
insulin ↓, glucagon ↓
corticosterone ↑, ghrelin ↑
[40] *
[56,57,58]
Frat3 Frat3lacZ
Peg12 tm1Brn
none [30] *
Mkrn3 Mkrn3 m+/p− lower weight from P45
earlier onset of puberty
GnRH1 ↑
[54] *
Magel2 Magel2m+/p−
Magel2 KO
C57BL/6-Magel2tm1Stw/J
(JAX009062, https://www.jax.org/strain/009062, accessed on 20 March 2021)
116HG expression ↓
postnatal lethality (~10%)
reduced weight until P28
body fat ↑
lean mass ↓
bone mineral density ↓
impaired glucose homeostasis
impaired cholesterol homeostasis
insulin resistance
leptin resistance
dopamine ↓, serotonin ↓
adiponectin ↑
corticosterones ↑
oxytocin ↓
different feeding behavior
less active
anxiety
impaired social behavior
delayed onset of puberty
progressive infertility
[53] *
[59,60,61,62,63,64,65,66,67,68,69,70,71,72]
Magel2 Magel2 m+/p−
Magel2 tm1.1Mus
postnatal lethality (~50%)
weak suckling
oxytocin ↓, orexin-A ↓
abnormal social behavior
impaired learning ability
[52] *
[73]
Magel2 (overexpression of truncated protein) CAG-trMagel2 neonatal lethality (100%)
small body size, poor suckling
[74] *
Necdin Ndn m+/p−
Ndn tm1Alb
none [51] *
Necdin Ndntm2Stw
B6.129S1(Cg)-Ndntm2Stw/J
(JAX009089, https://www.jax.org/strain/009089, accessed on 20 March 2021)
postnatal lethality (80–95% C57BL/6 and 25% FVB)
respiratory distress
[48] *
[75,76]
Necdin Ndnm+/p−
B6.129S2-Ndntm1.1Mus
postnatal lethality (21–31%)
respiratory distress
oxytocin ↓
serotonin ↓
[50] *
[77,78]
Necdin Ndn m+/p−
Ndn tm1Ky
respiratory abnormalities
DRG neuron apoptosis ↑
pain sensitivity ↓
noradrenergic excitability ↓
[49] *
[79]
Necdin Ndnm+/p−
Necdin KO
necdin m+/p−
unstable circadian rhythm [80] *
Snurf/Snrpn
Snord116
IPW
Snord115
Ube3a
Snrpn-Ube3a deletion
Del(7Ube3a-Snrpn)1Alb
neonatal lethality (80%)
growth retardation
hypotonia
[41] *
all (IC deletion) PWS-IC∆35kb
Snrpntm2Cbr
∆PWS-IC
PWS-ICdel
PWS-ICdel35kb
B6.129-Snrpntm2Cbr/J
(JAX012443, https://www.jax.org/strain/012443, accessed on 20 March 2021)
neonatal lethality (40–90% depending on background)
growth retardation
hypotonia
decreased locomotive ability
abnormal behavior
ghrelin ↑
increased food consumption
food-seeking behavior ↑
[45] *
[81,82,83,84,85,86]
all (IC deletion) PWS-IC m+/p del4.8kb
PWS-IC ∆4.8
Snrpn tm2Alb
neonatal lethality (40%)
growth retardation
[46] *
all, except Snrpn, Snord64, 116, 115 (IC deletion) PWS-IC Hs
Snrpn tm1Kaj
neonatal lethality (47% C57BL/6J and 16% 129S1/Sv)
growth retardation
feeding difficulties
[87] *
all (IC deletion) PWS-ICm+/p∆6kb
PWS-IC∆6kb
B6.129S1-Snrpntm2.1Kaj/J
(JAX018395, https://www.jax.org/strain/018395, accessed on 20 March 2021)
neonatal lethality (100%)
growth retardation
feeding difficulties
[47] *
Snord116/IPW PWScrm+/p−
Del(7Ipw-Snord116)1Jbro
(distributed by TRAM Münster)
neonatal lethality (15%)
growth retardation
pOx ↑, Peg3
decreased gray-matter volume
altered sleep profile
altered body temperature
[42] *
[88,89]
Snord116/IPW Snord116del
Snord116tm1Uta
Snord116+/−P
B6(Cg)-Snord116tm1.1Uta/J
(JAX008149, https://www.jax.org/strain/008149, accessed on 20 March 2021)
growth retardation
Igf1 ↓
ghrelin ↓
impaired pancreatic development
altered diurnal methylation
increased anxiety
altered respiratory exchange rate
resistant to obesity
[43] *
[90,91,92,93,94]
Snord116/IPW (homozygous) Snord116 m−/p−
Snord116 −/−
growth retardation
fat mass ↓
increased food consumption
altered diurnal activity profile
resistant to obesity
altered hypothalamic signaling
[95] *
Snord116/IPW (only Npy+ Neurons) Snord116lox/lox/NPYcre/+
(JAX008118, https://www.jax.org/strain/008118, accessed on 20 March 2021)
growth retardation
fat mass ↓
increased food consumption
altered diurnal activity profile
altered hypothalamic signaling
[95] *
Snord116/IPW
(adult-onset)
Snord116 deletion reduced food consumption
insulin resistance
[96] *
Snord116/IPW
(adult-onset)
AAV-Snord116delm+/p−
Snord116flAAV-Cre
increased food consumption
bodyweight ↑
bodyfat percentage ↑
[91] *
Snord115 Snord115-deficient brown adipose tissue ↑
modest alterations in 5-Htr2cr mRNA A-to-I editing
[44] *
Snord116 (single copy transgene) no effect on phenotype [43] *
Snord116
(transgene 2 mouse, 1 rat copies)
PWScrm+/p−TgSnord116 no effect on phenotype [97] *
Snord116 (transgene 27 copies) no effect on phenotype [98] *
all (biallelic IC deletion) PWS-ICm∆4.8kB/p∆4.8kB
PWS-ICm∆4.8kB/p∆S-U
rescue of postnatal lethality
rescue of growth retardation
[99]
Snord116/IPW (maternal IC deletion) PWScrm5′LoxP/p−
(distributed by TRAM Münster)
Rescue of growth retardation in adult mice
alterations in 5-Htr2cr mRNA A-to-I editing in the choroid plexus.
[97] *
Snord116 (AAV-mediated) Snord116delm−/p−AAV-Snord116 energy expenditure ↑
rate of weight gain ↓
[100] *

Original publications are marked by *, up- and downregulation of physiological parameters is represented by arrows (↑ and ↓).